Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Can Gilead Win In India Where Novartis Failed?

This article was originally published in PharmAsia News

Executive Summary

Gilead is walking the talk. It has now sued the Indian Patent Office in the Delhi High Court, challenging the Indian Patent Office over the decision to deny a patent on the metabolites of its blockbuster hepatitis C drug Sovaldi. But whether it will prevail where others have failed may come down to technical and legal definitions.

Topics

Related Companies

UsernamePublicRestriction

Register

SC088387

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel